InsidersTradesSigma
Follow the Sun Pharma Advanced share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €72.9bn. The latest transaction was reported on 21 May 2026 (Acquisition). Among the most active insiders: Shanghvi Finance Private Limited. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Sun Pharma Advanced is an Indian pharmaceutical company focused on the research and development of pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.